NEW YORK, Jan. 19, 2016 /PRNewswire/ -- This BCC Research report summarizes the global RNAi technologies market by category and by region. The RNAi market is analyzed based on RNAi research tools and reagents as well as on RNAi diagnostics. The report includes sales forecasts from 2015 to 2020.
Use this report to:
Analyze the market prospects of ribonucleic acid interference (RNAi) technology
Evaluate the product usage, research and development, collaborations, market trends
and future applications, prospects, challenges, etc. in the RNAi market Assess the progress of new RNAi techniques in the areas of research tools and products, therapeutics, diagnostics and agricultural segments
Gain information on the regulatory aspects, drivers and other factors of RNAi market
The global market for RNA interference technologies is expected to grow from $262.1 million in 2015 to $392.6 million in 2020, registering a compound annual growth rate (CAGR) of 8.4%.
The RNAi research tools and reagents market is projected to reach $391.0 million in 2020 from $261.1 million in 2015, increasing at a CAGR of 8.4%.
The RNAi diagnostics market reached $1.0 million in 2015 and should reach $1.6 million by 2020 growing at a CAGR of 9.9%.
BCC Research conducted this report to analyze the market prospects of ribonucleic acid interference (RNAi) technology. The report assesses the progress of new RNAi techniques in the areas of research tools and products, therapeutics, diagnostics andagricultural segments. Further, the report evaluates the product usage, research and development, collaborations, market trends and future applications, prospects, challenges, etc. in the RNAi market.
Global RNAi technology is in its nascent state. However, the market holds significant opportunities due to the promising application of RNAi therapeutics in often-fatal diseases like cancer, heart ailments, autoimmune diseases, neurodegenerative disease and others. The RNAi research tools and reagents market is growing well due to its major applications in RNAi therapeutics, diagnostics and agricultural areas. Secondly, various RNAi therapeutics candidates are showing success in advanced stages of their clinical investigations. Further, the availability of RNAi diagnostics tests offer great promises of successful application of RNAi therapeutics and diagnostics in medical settings.
The market projections are based on the commercialized research products and tools and trends in their applications, product development, applications in diagnostics, and investments for RNAi therapeutics, agricultural products and other areas. The report provides present market analysis as well as a projection for the next five years (until 2020). The report includes market analysis, market leaders, manufacturers and market shares, profiles of leading companies, current situations, new developments, patent analysis, regulatory aspects, drivers and other factors of RNAi market.
REASONS FOR DOING THIS STUDY
The RNAi market is burgeoning and is one of the most watched markets in the pharmaceuticals industry. The reason for this status is the encouraging application of RNAi mechanisms in therapeutics through gene silencing. There is no approved therapy so far; however, various candidates have shown successful results in their
clinical investigations. The report reflects the details of those candidates along with prospective applications of RNAi in diagnostics and agriculture. This market will grow through 2020 with the successful utilization of techniques in both therapeutics and agriculture.
Read the full report: http://www.reportlinker.com/p01715880-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001